| Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (NCT03446261) | Yuhan Corporation | 2018-02-23 |
| A First In Human Study to Assess CiVi007 in Subjects With an Elevated LDL-Cholesterol Level (NCT03427710) | Civi Biopharma, Inc. | 2018-02-07 |
| The Dual Impact of Homocysteine and Cholesterol on Cognitive Functions (NCT03631238) | Assiut University | 2018-01-15 |
| A Single Dose Escalation Study of PCSK9 Inhibitor (JS002) in Health Subjects (NCT04197817) | Shanghai Junshi Bioscience Co., Ltd. | 2017-12-11 |
| Single Ascending Dose Study of PCSK-9 Inhibitor (IBI306) in Healthy Subjects. (NCT03366688) | Innovent Biologics (Suzhou) Co. Ltd. | 2017-11-27 |
| Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia (NCT03175367) | Regeneron Pharmaceuticals | 2017-11-10 |
| Study to Evaluate the Safety, PK, and Pharmacodynamics of LIB003 (NCT03545438) | LIB Therapeutics LLC | 2017-10-30 |
| Effect of a Treatment With a Nutraceutical Combination on Sub-optimal LDL Cholesterol Levels (NCT03739242) | A. Menarini Industrie Farmaceutiche Riunite S.r.l. | 2017-10-12 |
| Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg (NCT04511000) | Chong Kun Dang Pharmaceutical | 2017-10-11 |
| The ZWOlle Transmural Integrated Care for CArdiovaScular Risk Management Study (NCT03428061) | UMC Utrecht | 2017-09-01 |
| Lipid-lowering Therapy Individualization (NCT03604471) | Université Catholique de Louvain | 2017-08-08 |
| Nutraceutical in Cardiovascular Primary Prevention (NCT03216811) | University Hospital of Ferrara | 2017-07-20 |
| Digital Ankle Brachial Index (ABI) as a Screening Tool in Detecting Peripheral Arterial Disease (NCT03161327) | St. Louis University | 2017-07-15 |
| Genetic Basis for Prediction of Non-responders to Dietary Plant Sterol Intervention (NCT02765516) | University of Manitoba | 2017-07-05 |
| Evaluation of the Effect of a Shiitake Extract on Lipid Profile in Subjects With Moderate Hyperlipidemia (NCT03550287) | Instituto de Investigación Hospital Universitario La Paz | 2017-05-08 |
| Phytosterol Supplementation and Lipoprotein Subfractions (NCT06127732) | Federal University of São Paulo | 2017-05-01 |
| Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg When Added to PCSK9 Inhibitor Therapy (NCT03193047) | Esperion Therapeutics, Inc. | 2017-04-07 |
| Evolocumab Versus LDL Apheresis in Patients With Hypercholesterolemia (NCT03429998) | Hospital General Universitario Gregorio Marañon | 2017-04-01 |
| Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE) (NCT03067441) | Esperion Therapeutics, Inc. | 2017-02-03 |
| Clinical Trial to Evaluate the Efficacy and Safety of DP-R212 (NCT02955368) | Alvogen Korea | 2017-02-01 |
| Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C (NCT03051100) | Esperion Therapeutics, Inc. | 2017-01-19 |
| NUtraceutical TReatment for hYpercholesterolemia in HIV-infected Patients (NCT03470376) | University Of Perugia | 2017-01-15 |
| A Defined, Plant-based, 4-week Dietary Intervention Reduces Lp(a) and Other Atherogenic Particles (NCT03172611) | Texas Woman's University | 2017-01-03 |
| Effects of Two Herbal Dietary Supplements on Lipid Metabolism in Moderate Hypercholesterolemia and Hypertriglyceridemia (NCT02989753) | Valbiotis | 2017-01-01 |
| Effect of β-cryptoxanthin (β-Cx), Plant Sterols and Galactooligosaccharides on Systemic and Gastrointestinal Markers (NCT03469518) | Puerta de Hierro University Hospital | 2017-01-01 |
| Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility) (NCT03001076) | Esperion Therapeutics, Inc. | 2016-11-29 |
| A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous (SC) Administered Alirocumab in Healthy Chinese Subjects (NCT02979015) | Sanofi | 2016-11-29 |
| The Combined Portfolio Diet and Exercise Study (NCT02481466) | Unity Health Toronto | 2016-11-25 |
| Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk (NCT02991118) | Esperion Therapeutics, Inc. | 2016-11-18 |
| Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant (NCT02988115) | Esperion Therapeutics, Inc. | 2016-11-16 |
| Effect of Red Yeast Rice, Phytosterols and L-tyrosol on Lipid Profile and Endothelial Function (NCT03065491) | University of Bologna | 2016-11-15 |
| Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia (NCT02984982) | Sanofi | 2016-11-15 |
| Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo (NCT02957682) | Regeneron Pharmaceuticals | 2016-11-02 |
| Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia (NCT02715726) | Sanofi | 2016-07-27 |
| LDL-cholesterol Lowering Effect of a New Dietary Supplement (NCT03425630) | Ispharm srl | 2016-07-01 |
| Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan (NCT02808403) | Amgen | 2016-06-24 |
| A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832) (NCT02741245) | Organon and Co | 2016-06-09 |
| Soy Modulation of Immune Activation, LDL- Levels, and Lowering Inflammation by Pretzel Isoflavone Dietary Intervention (NCT02818283) | Ohio State University | 2016-06-01 |
| Plant-Based, American Heart Assoc. or Mediterranean Diets In 9-18 yo With BMI >95%, Cholesterol >169 and Their Parents (NCT02857543) | The Cleveland Clinic | 2016-06-01 |
| Feasibility and Acceptability of a Beverage Intervention for Hispanic Adults (NCT02911753) | University of Arizona | 2016-06-01 |
| A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833) (NCT02748057) | Organon and Co | 2016-05-18 |
| Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia (NCT02739984) | Amgen | 2016-05-17 |
| Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2) (NCT03074630) | Amsterdam UMC, location VUmc | 2016-05-01 |
| A Study to Evaluate the Effects of Dietary Fiber on Blood Lipids in Men and Women (NCT02835872) | Tate & Lyle | 2016-05-01 |
| Nutraceuticals and Vascular Remodelling (NCT04433429) | Marcello Rattazzi | 2016-05-01 |
| Efficacy of a Red Yeast Rice Based Nutraceutical Plus Probiotic in Patients With Moderate Hypercholesterolemia (NCT02689934) | Montefarmaco OTC SpA | 2016-04-01 |
| A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study) (NCT02749994) | IlDong Pharmaceutical Co Ltd | 2016-04-01 |
| The Effects of a Spread With Added Plant Sterols and Omega-3 Fatty Acids on Blood Lipids (NCT02728583) | Unilever R&D | 2016-04-01 |
| Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects (NCT02681055) | MediciNova | 2016-03-01 |
| Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy (NCT02694094) | Johns Hopkins University | 2016-03-01 |
| Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe (NCT02772640) | Collegium Medicum w Bydgoszczy | 2016-03-01 |
| Effect of Amlodipine on the Lipid Profile of Newly Diagnosed Hypertensive Patients (NCT05467384) | Ayub Teaching Hospital | 2016-03-01 |
| Efficacy of a LRC™ (L. Reuteri NCIMB 30242) Capsule on Managing Cholesterol in Adults (NCT02734706) | UAS Labs LLC | 2016-03-01 |
| Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-4 (NCT02634580) | Amgen | 2016-02-27 |
| Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony) (NCT02666664) | Esperion Therapeutics, Inc. | 2016-01-21 |
| The Cholesterol Lowering Effects of Strawberry (NCT02612090) | Clinical Nutrition Research Center, Illinois Institute of Technology | 2016-01-04 |
| Lipid Lowering Effect of a Cereal Based Snack Bar With Added Plant Stanol Ester (NCT03284918) | Raisio Group | 2016-01-01 |
| Graves' Orbitopathy and Hypercholesterolemia (NCT02721992) | University of Pisa | 2016-01-01 |
| Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment (NCT02585895) | Amgen | 2015-12-21 |
| Sí Texas Hope Family Health Center (NCT03916016) | Health Resources in Action, Inc. | 2015-12-09 |
| EFFECTS OF CARDICHOL, AN HERBAL DIETARY SUPPLEMENT, IN MODERATE HYPERCHOLESTEROLEMIA (NCT02657759) | Direct Plantes | 2015-12-01 |
| Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin (NCT02584504) | Sanofi | 2015-11-30 |
| Reverse Colocated Integrated Care Intervention Among Persons With Severe Persistent Mental Illness at US-Mexico Border (NCT03881657) | Health Resources in Action, Inc. | 2015-11-24 |
| Assessing Outcomes of Enhanced Chronic Disease Care Through Patient Education and a Value-based Formulary Study (NCT02579655) | University of Calgary | 2015-11-01 |
| Measuring the Impact of Dietary Supplementation With a New Baking Product on Gut Microbiota and Cholesterol Metabolism (NCT02664428) | Fondazione Edmund Mach | 2015-11-01 |
| Single Dose Study of PF-06815345 in Healthy Subjects (NCT02654899) | Pfizer | 2015-11-01 |
| Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients (NCT03949374) | Yonsei University | 2015-10-23 |
| Effect On Serum Cholesterol Of Dairy Products With Addition Of Esterified Phytosterols (NCT02644109) | University of Chile | 2015-10-01 |
| A Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hypercholesterolemia (NCT02608697) | Catabasis Pharmaceuticals | 2015-10-01 |
| A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383) (NCT02550288) | Organon and Co | 2015-09-29 |
| Validating the "Foods for Health" Portfolio of Functional Food Products (NCT02341924) | University of Manitoba | 2015-09-01 |
| Electronic Medical Records and Genomics (eMERGE) Phase III (NCT03394859) | Vanderbilt University Medical Center | 2015-09-01 |
| Study Assessing Safety, Immunogenicity and LDLc -Lowering Activity of 2 PCSK9 Targeting AFFITOPE Vaccines in Healthy Subjects (NCT02508896) | Affiris AG | 2015-07-01 |
| Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE) (NCT02476006) | Sanofi | 2015-06-23 |
| Proteus Discover in Subjects With Uncontrolled Hypertension and Type 2 Diabetes (NCT02827630) | Proteus Digital Health, Inc. | 2015-05-01 |
| Nattokinase Supplementation and Hemostatic Factors (NCT02913170) | Yonsei University | 2015-05-01 |
| Hypocholesterolemic Effect of Fibracep (NCT04545463) | Universitat de Lleida | 2015-05-01 |
| Lipid-lowering Effect of Phytosterols, Red Yeast Rice and Their Combination (NCT02603276) | University of Bologna | 2015-04-01 |
| Atorvastatin Study in Cardiovascular Disease Risk (NCT02392416) | Elpen Pharmaceutical Co. Inc. | 2015-04-01 |
| Effects of α-linolenic Acid Supplementation on Hemostasis in Nondiabetic and Hypercholesterolemic Subjects (NCT02609295) | Yonsei University | 2015-02-01 |
| Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan (NCT02289963) | Sanofi | 2015-01-01 |
| A 2-Part, Phase 1, Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CAT-2054 in Healthy Subjects (NCT02374047) | Catabasis Pharmaceuticals | 2015-01-01 |
| A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary Hypercholesterolemia (NCT02260648) | Eli Lilly and Company | 2015-01-01 |
| Postprandial Lipemia and Glycemia Following a High-Fat Meal (NCT05619952) | State University of New York at Buffalo | 2014-12-29 |
| Open-label Extension (OLE) Study to Assess Safety and Efficacy of Evolocumab (NCT02304484) | Amgen | 2014-11-24 |
| Retinoic Acid Supplementation and Subjects With Hypercholesterolemia (NCT02497833) | Sun Yat-sen University | 2014-11-01 |
| Phase 3 Study to Evaluate the Efficacy and Safety of the DW0929 in Patients With Primary Hypercholesterolemia (NCT02390375) | Daewon Pharmaceutical Co., Ltd. | 2014-11-01 |
| Genome-wide Analysis of Lipid-lowering Efficacy and Drug Level of Simvastatin and Rosuvastatin (NCT04921657) | Chinese University of Hong Kong | 2014-11-01 |
| A Study of Evacetrapib (LY2484595) in Japanese Participants With Primary Hypercholesterolemia (NCT02260635) | Eli Lilly and Company | 2014-11-01 |
| The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia (NCT03288038) | Shin Poong Pharmaceutical Co. Ltd. | 2014-10-13 |
| Combination of AB-LIFE Probiotic Plus Monacolin K to Reduce Blood Cholesterol (NCT04677335) | AB Biotics, SA | 2014-10-01 |
| The Effect of Plant Sterols on the Blood Lipid Profile of Subjects With and at High Risk of Type 2 Diabetes Mellitus (NCT02288585) | Unilever R&D | 2014-10-01 |
| Vascular Lifestyle-Intervention and Screening in Pharmacy (NCT02223793) | University of Oslo | 2014-09-01 |
| The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (NCT02251847) | IlDong Pharmaceutical Co Ltd | 2014-07-01 |
| The Effect of Shuhua Milk Fortified With Plant Sterol Esters on Serum Cholesterol in Human (NCT02475018) | Inner Mongolia Yili Industrial Group Co., Ltd | 2014-07-01 |
| Evaluation of ETC-1002 in Participants With Hypercholesterolemia and Hypertension (NCT02178098) | Esperion Therapeutics, Inc. | 2014-06-16 |
| Short Term Intermittent Fasting and Mediterranean Diet (NCT02148458) | Washington University School of Medicine | 2014-06-01 |
| Lipid-lowering Effect of a Plant Stanol Ester Supplement Product (NCT02221297) | Raisio Group | 2014-05-01 |
| Replacement of Saturated Fat in Dairy on Total Cholesterol (NCT02089035) | University of Reading | 2014-05-01 |
| Cardiovascular Risk Factors And Intensive Dietary Counselling (NCT02173600) | Andalusian Regional Ministry of Health | 2014-05-01 |